About
First Name:
Last Name:
Title and Organization:
Bio:
John Marotta is the President and Chief Executive Officer of PHC Group, a diversified global life sciences, diagnostics and medical device company focused on precision healthcare, with 10,000 employees globally in over 125 countries. PHC Group publicly traded company on the Tokyo Stock Exchange, with private equity shareholders like KKR, Mitsui & Co, L-Catterton, Panasonic and Mitsubishi. PHC headquarters in Tokyo, Japan and global operations in the US and Europe.
Marotta has more than 20 years of experience in the medical devices, life sciences and diagnostics, focused on business transformation, commercial, operations, M&A and carveout. He brings a strong commitment to driving business performance serving customers and employees. Prior to PHC Group CEO, Marotta was the President of Epredia, a PHC Group operating company. Epredia a life sciences carveout from ThermoFisher focused anatomic pathology, immunohistochemistry and digital pathology.
Prior to joining Epredia, Marotta was a Senior Vice President of Envista Holdings a dental medical device spinout from Danaher in 2019. In this role, he oversaw various global functions, and was on the senior team that led the company to a successful IPO. At Danaher, John was the Senior Vice President of Dental Platform, with six global functions. John originally joined Danaher as Vice President & General Manager of KaVoKerr Restoratives.
Prior to joining Danaher, he held various roles and executive positions in global healthcare and medical device businesses at Cardinal Health and Emerge Medical. John started his career at Johnson & Johnson operating companies, where he held various commercial roles at Synthes Orthopaedics (prior to DePuy acquisition) and Janssen. Marotta is a Fellow of the inaugural class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network. He has a BS from the University of Dayton and an MBA from the University of Denver.
Fellowship Program
Class
